Belite Bio, Inc. ADR(BLTE)
$155.94-0.58 (-0.37%)
BLTE
Belite Bio, Inc. ADR financials statements
$155.94
At close:-0.58 (-0.37%)
Want to see BLTE full AI Analyst Report?
Belite Bio, Inc. ADR (BLTE) Ratios
76 Followers
Belite Bio, Inc. ADR Ratios
BLTE's free cash flow for Q2 2026 was $0.00. For the 2026 fiscal year, BLTE's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 50.02 | 24.31 | 24.76 | 20.35 | 10.66 |
| Quick Ratio | 50.02 | 24.31 | 24.76 | 20.35 | 10.66 |
| Cash Ratio | 35.71 | 5.24 | 24.27 | 20.00 | 10.61 |
| Solvency Ratio | -7.66 | -5.66 | -7.42 | -4.49 | -0.29 |
| Operating Cash Flow Ratio | -3.74 | -4.83 | -8.21 | -5.45 | -4.57 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | -96.87 | -57.87 | 0.00 |
| Net Current Asset Value | $ 484.20M | $ 140.76M | $ 85.73M | $ 40.03M | $ -16.01M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.01 | 0.02 | 1.73 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.01 | 0.02 | -2.11 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.01 | 0.02 | 1.90 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 1.90 |
| Financial Leverage Ratio | 1.01 | 1.04 | 1.05 | 1.07 | -1.22 |
| Debt Service Coverage Ratio | 0.00 | -1783.75 | -93.72 | -58.10 | 0.00 |
| Interest Coverage Ratio | 0.00 | -1999.80 | -1266.72 | -801.31 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 |
| Interest Debt Per Share | 0.01 | 0.02 | 0.03 | 0.04 | 1.32 |
| Net Debt to EBITDA | 4.57 | 0.87 | 2.80 | 3.32 | -1.50 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.02% | 100.03% | 100.00% | 100.00% |
| EBT Per EBIT | 92.17% | 90.35% | 99.86% | 98.65% | 98.66% |
| Return on Assets (ROA) | -9.94% | -23.76% | -33.42% | -28.57% | -52.68% |
| Return on Equity (ROE) | -10.07% | -24.79% | -34.98% | -30.48% | 64.04% |
| Return on Capital Employed (ROCE) | -10.93% | -27.38% | -34.80% | -30.40% | -58.62% |
| Return on Invested Capital (ROIC) | -10.92% | -27.33% | -34.56% | -30.12% | -58.62% |
| Return on Tangible Assets | -10.01% | -24.40% | -34.61% | -28.59% | -52.68% |
| Earnings Yield | -1.45% | -1.88% | -2.60% | -2.10% | -3.79% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.10 | -0.96 | -1.12 | -0.57 | -0.31 |
| Free Cash Flow Per Share | -1.11 | -0.96 | -1.12 | -0.59 | -0.31 |
| Dividend Paid and CapEx Coverage Ratio | -207.80 | -193.60 | -473.60 | -29.08 | -101.00 |
| Capital Expenditure Coverage Ratio | -207.80 | -193.60 | -473.60 | -29.08 | -101.00 |
| Operating Cash Flow Coverage Ratio | -86.22 | -54.44 | -33.68 | -13.23 | -0.23 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -0.69% | -1.52% | -2.46% | -1.97% | -2.96% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -69.25 | -53.31 | -38.46 | -47.61 | -26.40 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 6.96 | 13.21 | 13.45 | 14.51 | -16.91 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -144.35 | -65.58 | -40.69 | -50.81 | -33.81 |
| Price-to-Operating Cash Flow Ratio | -145.04 | -65.92 | -40.78 | -52.56 | -34.14 |
| Price-to-Earnings Growth (PEG) Ratio | -0.72 | 63.44 | -0.43 | -0.83 | 0.74 |
| Enterprise Value Multiple | -64.97 | -53.15 | -36.20 | -45.12 | -27.98 |
| Enterprise Value | 5.01B | 1.90B | 1.13B | 560.97M | 269.63M |
| EV to EBITDA | -64.97 | -53.15 | -36.20 | -45.12 | -27.98 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -134.86 | -64.52 | -37.77 | -47.33 | -35.72 |
| EV to Operating Cash Flow | -135.51 | -64.85 | -37.85 | -48.96 | -36.08 |
| Tangible Book Value Per Share | 22.83 | 4.64 | 3.28 | 2.08 | -0.63 |
| Shareholders’ Equity Per Share | 22.97 | 4.78 | 3.40 | 2.08 | -0.63 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.00 | -0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -2.31 | -1.18 | -1.19 | -0.63 | -0.40 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.48 | 0.81 | 0.94 | 0.91 | 0.77 |
Currency in USD
